University of Thessaly (UTH)
Πρότυπα συνταγογράφησης και εκτίμηση κόστους με τη βοήθεια μεγάλων δεδομένων σε νοσήματα πνευμόνων
Abstract
dc:descriptionThis dissertation presents the usefulness of prescription standards with the help of big data for cost estimation of the cost of lung diseases.The material of the study concerned data from the electronic prescribing system of the National Organization for the Provision of Health Services and was retrospective. Specifically, in the 1st chapter of the special part, 101,426 electronic prescriptions were analyzed and their distribution was made per ICD10 for Pulmonary Embolism while the respective total prevalence was measured as well as the prevalence of men, women and by geographical area. The analysis of electronic prescriptions by physician specialty was also calculated. In the 2nd part, 29,787 electronic prescriptions were analyzed which related to ICD10 of the Other Intermediate Diseases with Fibrosis in terms of their distribution by year, by sex, while the prevalence of the disease was estimated. The distribution of electronic prescriptions by physician specialty was also calculated. In the 3rd part, the estimation of the pharmaceutical cost of Pulmonary Embolism in Greece was performed from data obtained from the Pulmonary Embolization Clinic of the University General Hospital of Larissa, which were displayed in the data available from EOPYY.The methodology followed for the analysis of the results involved the use of the statistical program SPSS (22.0). The results present for the first time the prevalence of Pulmonary Embolism and Other Intermediate Diseases with Fibrosis for Greece for the years 2013 - 2017. Regarding Pulmonary Embolism an increasing trend for the prevalence of Pulmonary Embolism was found for all these study years with the prevalence of women being higher than men with a higher increasing trend. Also in Other Interstitial Diseases with Fibrosis an increasing trend was observed for the prevalence of the disease for all these years with the prevalence of males being higher than females. Finally, regarding the estimation of outpatient pharmaceutical costs for the treatment of Pulmonary Embolism for Greece for the years 2013-2017, it seems to be increasing over the years and this is mainly due to DOACs, probably due to the high market penetration of these drugs.The present results can be used to effectively organise national health care systems' campaigns for the diagnosis, treatment and prevention of the two Lung Diseases. Also, the cost estimation will help for formulating and making rational decisions on health policies.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lampropoulos, Ioannis
- Λαμπρόπουλος, Ιωάννης
Subjects
dc:subject × 34- Οικονομικά της υγείας
- Πνευμονική εμβολή
- Διάμεσες πνευμονοπάθειες
- Σύστημα ηλεκτρονικού φακέλου υγείας (ΗΦΥ)
- Πρότυπα συνταγογράφησης
- Κόστος
- Κόστος ασθενειών
- Μεγάλα δεδομένα (BigData)
- Πνευμονικά νοσήματα
- Health economics
- Pulmonary embolism
- Interstitial lung disease
- Electronic health record system (EHS)
- Prescription standards
- Cost
- Disease costs
- BigData
- Lung diseases
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιδημιολογία
- Ιατρική Πληροφορική
- Οικονομικά και Επιχειρήσεις
- Κοινωνικές Επιστήμες
- Οικονομικά
- Λογιστική
- Health Sciences
- Medical and Health Sciences
- Epidemiology
- Medical Informatics
- Economics and Business
- Social Sciences
- Ecomonics
- Accounting
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51517